Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for the treatment of COVID-19 comprising administering replication-defective adenoviruses encoding the SARS-CoV-2 spike glycoprotein and modified nucleocapsid protein

Methods for the treatment of COVID-19 comprising administering replication-defective adenoviruses encoding the SARS-CoV-2 spike glycoprotein and modified nucleocapsid protein

US Patent 12285481 · Granted Apr 29, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Conditional modulation of therapy using recombinant cells2025
Live cell imaging systems and methods to validate triggering of immune response2025
Method of characterizing a tumor based on an immune gene expression signature in2025
Mesenchymal stem cell derived exosomes and methods2025
RP182 compositions and methods2025
Cellular adjuvants for viral infection2025
Cellular adjuvants for viral infection2025
Targeted neoepitope vectors and methods therefor2025
HIV treatment compositions and methods2025
Prediction of computational pathway circuits2025
SARS-CoV-2 vaccines comprising human adenovirus vectors encoding spike and nucle2025
Reprogrammed T cell-like NK cells2025